Stryker Corporation reports developments as a global medical technology company serving MedSurg, Neurotechnology and Orthopaedics markets. Company news commonly covers operating results, organic sales trends, segment performance, dividends, shareholder-meeting activity and executive finance or investor-relations appointments.
Stryker updates also address portfolio expansion across medical devices, implants, instruments, operating-room equipment, neurotechnology and vascular solutions. Recent corporate activity includes the completed acquisition of Amplitude Vascular Systems, adding an intravascular lithotripsy platform for peripheral arterial disease to Stryker's peripheral vascular portfolio.
Stryker (NYSE:SYK) reported third-quarter 2026 sales of $6.5 billion, with growth accompanied by a decline in reported earnings. Sales rose 7.7% year over year, including 7.7% organic growth, which excludes currency effects and acquisitions or divestitures. Net earnings fell 12.3% to $753 million, and diluted earnings per share fell 11.7% to $1.96. Operating margin declined to 15.9% from 18.7%.
Adjusted earnings per share, excluding specified items, rose 10.3% to $3.52, while adjusted operating margin increased 60 basis points to 26.2%. Stryker said performance fell short of its expectations. Its updated 2026 outlook calls for organic sales growth of 6.5% to 7.0% and adjusted diluted earnings per share of $14.80 to $14.90. The company repurchased $1.0 billion of stock during the quarter; its board approved a $3.0 billion increase to the repurchase program in October 2026.
Stryker (SYK) will participate in the 2026 Jefferies Global Healthcare Conference in London on November 17, 2026.
Spencer Stiles, President and Chief Operating Officer, Preston Wells, Vice President and Chief Financial Officer, and Nick Mead, Vice President of Investor Relations, will join a fireside chat at 8:30 a.m. Greenwich Mean Time. A live audio webcast and replay will be available through Stryker’s Events & Presentations page.
Stryker (NYSE:SYK) has completed its acquisition of ZuriMED, adding a commercialized rotator cuff augmentation technology to its Sports Medicine portfolio.
ZuriMED, a privately held company, developed the FiberLocker System, which is designed to increase the biomechanical strength of a rotator cuff repair. Stryker said the addition expands its ability to support shoulder surgeons across shoulder care. Management sees an opportunity to advance the technology and expand access to treatment options.
Stryker (SYK) has received FDA 510(k) clearance for Sonopet 3, its latest ultrasonic bone and soft tissue removal platform.
Developed with input from hundreds of surgeons, the platform includes RISE for connected surgical workflows and Pulse Control to regulate tissue removal. Stryker expects the first clinical cases in October, with a full commercial launch anticipated later this fall.
Stryker (NYSE:SYK) announced an alliance with CMR Surgical that includes an approximately $400 million preferred equity investment in the robotics company.
The investment, also stated as £300 million, is intended to support future innovation and global commercialization of the Versius surgical robotic portfolio. Stryker will serve as the portfolio’s exclusive U.S. sales agent, while CMR Surgical will continue to lead portfolio development and commercialization outside the United States.
Stryker also receives an exclusive option to acquire 100% of CMR Surgical’s outstanding equity in the future, subject to the agreement’s terms. The transaction remains subject to regulatory approvals and customary closing conditions. Stryker describes the alliance as an entry into soft-tissue robotics that complements its endoscopy and visualization businesses.
Stryker (SYK) appointed President and Chief Operating Officer Spencer Stiles as its next Chief Executive Officer, effective January 1, 2027. Stiles will also join the Board of Directors at that time. Current CEO Kevin Lobo will transition to Executive Chair on the same date as part of a planned succession process.
Stiles joined Stryker’s Endoscopy business in 1999 and became President and Chief Operating Officer in January 2026. He previously served as Group President, Orthopaedics. Lobo became CEO in October 2012 and Board Chair in July 2014.
Stryker (NYSE: SYK) will host a webcast on October 29, 2026, to discuss its third quarter 2026 financial results. The webcast begins at 4:30 p.m. Eastern time, with a financial results press release scheduled for approximately 4:05 p.m. Eastern time that day. A webcast archive will be available on Stryker’s website beginning approximately two hours after the live call ends.
Stryker (SYK) is launching Prophecy® Surgical Planning for its Incompass™ Total Ankle System and introducing Hoffmann® LRF smartHEX™ at the 2026 AOFAS Annual Meeting in Seattle.
Prophecy Surgical Planning, which has supported patient-specific planning in more than 100,000 ankle cases over 14 years, now gives Incompass users 3D visualization plus resect-through and pin-through fixation options in a single platform. Hoffmann LRF smartHEX expands the limb reconstruction portfolio with new rings, struts and frame components, alongside a mobile app and updated planning software designed to enhance frame versatility and support connected care between surgeons and patients.
Stryker (SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at Encore Boston Harbor.
Vice President and CFO Preston Wells and Vice President, Investor Relations Nick Mead will join a fireside chat at 10:15 a.m. Eastern time. A live audio webcast and replay will be available via Stryker's Events & Presentations webpage.
Stryker (NYSE: SYK) announced the first successful surgical use of its FDA De Novo authorized SportSuite Vision application on Apple Vision Pro during a hip arthroscopy at Duke Health, a leading academic medical center, on September 1, 2026.
SportSuite Vision, authorized on July 17, is the first application cleared by the FDA for intraoperative use with Apple Vision Pro. The system brings arthroscopic video, HipCheck, HipMap and CT imaging into a customizable spatial computing environment, enabling surgeons to view physical objects alongside multiple digital data streams within one ergonomic field of view. According to Stryker, this configuration can reduce reliance on traditional monitors and support more streamlined, ergonomic operating room workflows during arthroscopic procedures.